Bayer | BAYN - Ordinary Share Capital


Bayer reported EUR982.42M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Air Liquide EUR 577.57M 2.6B Dec/2025
Akzo Nobel EUR 171.31M 200K Mar/2026
Alcon AG USD 487.4M 0 Mar/2026
Amarin USD 20.81M 13K Dec/2025
Arkema EUR 75.67M 29K Mar/2026
AstraZeneca USD 1.55B 73K Mar/2026
BASF EUR 892.52M 249.48M Sep/2025
Bayer EUR 982.42M 0 Dec/2025
Beiersdorf EUR 218.92M 1.29M Dec/2025
Corteva USD 670.04M 2.12M Mar/2026
Covestro EUR 207.64M 18.9M Dec/2025
Essilor EUR 463.05M 1.9M Dec/2025
Fresenius EUR 563.24M 0 Dec/2025
Fresenius Medical Care EUR 270.09M 9.2M Mar/2026
Genmab DKK 61.62M 52K Dec/2025
Givaudan CHF 9.23M 0 Dec/2025
GlaxoSmithKline GBP 4.05B 20.6M Mar/2026
GRIFOLS EUR 680.58M 0 Mar/2026
Henkel EUR 406.79M 7.18M Dec/2025
Hikma Pharmaceutical USD 221.89M 181.89M Dec/2025
Johnson Matthey GBP 168.06M 0 Jun/2026
Linde USD 462.6M 1.08M Mar/2026
Lonza CHF 68.64M 0 Dec/2025
Merck EUR 434.78M 0 Mar/2026
Novartis USD 1.91B 60K Mar/2026
Nutrien USD 481.96M 2.37M Dec/2025
Philips EUR 952.02M 729K Mar/2026
PPG Industries USD 223.43M 973K Dec/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
Sanofi EUR 1.21B 8.25M Mar/2026
SAP EUR 1.17B 86K Dec/2025
Solvay EUR 104.48M 18K Mar/2026
UCB EUR 190.36M 365.15K Dec/2025
Umicore EUR 240.56M 1.14B Dec/2025
Vinci EUR 555.97M 3.66M Dec/2025